BiotechTube

Arm 1 Cataract Surgery performed with remimazolam as sedative + Arm 2 Cataract Surgery performed with standard of care sedative

ApprovedRecruiting
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Cataract Surgery Anesthesia

Conditions

Cataract Surgery Anesthesia

Trial Timeline

Feb 15, 2026 → Dec 1, 2027

NCT ID
NCT07325227

About Arm 1 Cataract Surgery performed with remimazolam as sedative + Arm 2 Cataract Surgery performed with standard of care sedative

Arm 1 Cataract Surgery performed with remimazolam as sedative + Arm 2 Cataract Surgery performed with standard of care sedative is a approved stage product being developed by Eagle Pharmaceuticals for Cataract Surgery Anesthesia. The current trial status is recruiting. This product is registered under clinical trial identifier NCT07325227. Target conditions include Cataract Surgery Anesthesia.

Hype Score Breakdown

Clinical
30
Activity
20
Company
2
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT07325227ApprovedRecruiting

Competing Products

20 competing products in Cataract Surgery Anesthesia

See all competitors
ProductCompanyStageHype Score
ISV-305Sun PharmaceuticalPhase 3
77
ISV-303 + Bromday™Sun PharmaceuticalPhase 2
52
ISV-305Sun PharmaceuticalPhase 3
77
DE-108 + Levofloxacin 0.5%Santen PharmaceuticalPhase 3
77
Prednisolone acetateNovartisApproved
85
Omidria + Dextenza (dexamethasone ophthalmic insert) 0.4mg + Dexycu, 9% Intraocular Suspension + Prednisolone Acetate 1%Ocular TherapeutixApproved
80
Dextenza 0.4Mg Ophthalmic InsertOcular TherapeutixApproved
80
Dextenza Ophthalmic Insert + Prednisolone acetate ophthalmic suspension USP 1%Ocular TherapeutixPhase 3
72
Dextenza 0.4Mg Ophthalmic Insert + Prednisolone Acetate 1% Ophthalmic Suspension [PRED FORTE]Ocular TherapeutixPhase 2/3
60
Dexamethasone 0.4 MG [Dextenza]Ocular TherapeutixApproved
80
Dextenza 0.4Mg Ophthalmic Insert + Topical prednisolone acetateOcular TherapeutixApproved
80
Dextenza 0.4mg intracanalicular Insert + Durezol 0.05% Ophthalmic EmulsionOcular TherapeutixApproved
80
DexycuEyePoint PharmaceuticalsPhase 3
72
Dexycu + Standard of Care post operative eye drops (steroid, antibiotic, NSAID)EyePoint PharmaceuticalsApproved
80
DexycuEyePoint PharmaceuticalsPhase 3
72
DEXYCU (dexamethasone intraocular suspension) 9%.EyePoint PharmaceuticalsPre-clinical
18
Dexamethasone + Prednisolone Acetate OphthalmicEyePoint PharmaceuticalsApproved
80
Bimatoprost Implant System (High Dose) + Bimatoprost Implant System (Low Dose) + Timolol Maleate Ophthalmic Solution, 0.5%SpyGlass PharmaPhase 1/2
36
Bimatoprost Implant System + Timolol Maleate Ophthalmic Solution, 0.5%SpyGlass PharmaPhase 3
72
Bimatoprost Implant System + Timolol Maleate Ophthalmic Solution, 0.5%SpyGlass PharmaPhase 3
72

Other Products from Eagle Pharmaceuticals

Placebo + Mesalamine + MesalaminePhase 3
69
Ryanodex and Standard of CarePhase 3
69
CAL02 + PlaceboPhase 2
44
Ryanodex (dantrolene sodium) for injectable suspensionPhase 2
44
Dantrolene sodium for injectable suspensionPhase 2
44